PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Clinical trials for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA trials appear
Sign up with your email to follow new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cholesterol shot enters final testing phase
Disease control Not yet recruitingThis study is testing an experimental injectable drug called QLC7401 for people with high cholesterol that isn't well-controlled with their current medication. The main goal is to see if it safely lowers 'bad' LDL cholesterol more than a placebo injection. It will involve about 7…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New shot aims to zap bad cholesterol
Disease control Not yet recruitingThis study is testing a new injectable drug called QLC7401 to see if it safely lowers 'bad' cholesterol (LDL-C) in adults. It will involve 510 people with high cholesterol who are not currently taking other cholesterol medications. Participants will receive either the real drug o…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC